Document is current
Any future updates will be listed below
-
Authors
Vega Magdaleno, Gustavo Daniel
de Magalhães, João Pedro
-
Funding
Funding for this research was provided by:
Wellcome Trust (208375/Z/17/Z)
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 2 April 2026
First Online: 29 April 2026
Declarations
:
: JPM is the CSO of YouthBio Therapeutics, an advisor and consultant for the BOLD Longevity Growth Fund and NOVOS, and the founder of Magellan Science Ltd., a company providing consulting services in longevity science.
